FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3181426805> ?p ?o ?g. }

• W3181426805 endingPage "100164" @default.
• W3181426805 startingPage "100164" @default.
• W3181426805 abstract "Monoclonal antibodies (mAb) have been introduced as a promising new therapeutic approach against SARS-CoV-2. At present, there is little experience regarding their clinical effects in patient populations underrepresented in clinical trials, e.g. immunocompromised patients. Additionally, it is not well known to what extent SARS-CoV-2 treatment with monoclonal antibodies could trigger the selection of immune escape viral variants.After identifying immunocompromised patients with viral rebound under treatment with bamlanivimab, we characterized the SARS-CoV-2-isolates by whole genome sequencing. Viral load measurements and sequence analysis were performed consecutively before and after bamlanivimab administration.After initial decrease of viral load, viral clearance was not achieved in five of six immunocompromised patients treated with bamlanivimab. Instead, viral replication increased again over the course of the following one to two weeks. In these five patients, the E484K substitution - known to confer immune escape - was detected at the time of viral rebound but not before bamlanivimab treatment.Treatment of SARS-CoV-2 with bamlanivimab in immunocompromised patients results in the rapid development of immune escape variants in a significant proportion of cases. Given that the E484K mutation can hamper natural immunity, the effectiveness of vaccination as well as antibody-based therapies, these findings may have important implications not only for individual treatment decisions but may also pose a risk to general prevention and treatment strategies.All authors are employed and all expenses covered by governmental, federal state, or other publicly funded institutions." @default.
• W3181426805 created "2021-07-19" @default.
• W3181426805 creator A5000874547 @default.
• W3181426805 creator A5025235476 @default.
• W3181426805 creator A5036504573 @default.
• W3181426805 creator A5047978331 @default.
• W3181426805 creator A5048678982 @default.
• W3181426805 creator A5052701171 @default.
• W3181426805 creator A5059354710 @default.
• W3181426805 creator A5061035699 @default.
• W3181426805 creator A5061663931 @default.
• W3181426805 creator A5063480612 @default.
• W3181426805 creator A5068290703 @default.
• W3181426805 creator A5074659603 @default.
• W3181426805 creator A5084597097 @default.
• W3181426805 creator A5086084987 @default.
• W3181426805 creator A5090810460 @default.
• W3181426805 date "2021-09-01" @default.
• W3181426805 modified "2023-10-16" @default.
• W3181426805 title "Emergence of the E484K mutation in SARS-COV-2-infected immunocompromised patients treated with bamlanivimab in Germany" @default.
• W3181426805 cites W1519765314 @default.
• W3181426805 cites W2021341670 @default.
• W3181426805 cites W2346116821 @default.
• W3181426805 cites W2553911297 @default.
• W3181426805 cites W2581539849 @default.
• W3181426805 cites W2616925143 @default.
• W3181426805 cites W3001195213 @default.
• W3181426805 cites W3033981377 @default.
• W3181426805 cites W3047151171 @default.
• W3181426805 cites W3102798166 @default.
• W3181426805 cites W3125712166 @default.
• W3181426805 cites W3128154910 @default.
• W3181426805 cites W3129265543 @default.
• W3181426805 cites W3129875542 @default.
• W3181426805 cites W3132891189 @default.
• W3181426805 cites W3133794453 @default.
• W3181426805 cites W3149428818 @default.
• W3181426805 cites W3175889053 @default.
• W3181426805 cites W3178509854 @default.
• W3181426805 cites W3185488876 @default.
• W3181426805 doi "https://doi.org/10.1016/j.lanepe.2021.100164" @default.
• W3181426805 hasPubMedCentralId "https://www.ncbi.nlm.nih.gov/pmc/articles/8278033" @default.
• W3181426805 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/34278371" @default.
• W3181426805 hasPublicationYear "2021" @default.
• W3181426805 type Work @default.
• W3181426805 sameAs 3181426805 @default.
• W3181426805 citedByCount "71" @default.
• W3181426805 countsByYear W31814268052021 @default.
• W3181426805 countsByYear W31814268052022 @default.
• W3181426805 countsByYear W31814268052023 @default.
• W3181426805 crossrefType "journal-article" @default.
• W3181426805 hasAuthorship W3181426805A5000874547 @default.
• W3181426805 hasAuthorship W3181426805A5025235476 @default.
• W3181426805 hasAuthorship W3181426805A5036504573 @default.
• W3181426805 hasAuthorship W3181426805A5047978331 @default.
• W3181426805 hasAuthorship W3181426805A5048678982 @default.
• W3181426805 hasAuthorship W3181426805A5052701171 @default.
• W3181426805 hasAuthorship W3181426805A5059354710 @default.
• W3181426805 hasAuthorship W3181426805A5061035699 @default.
• W3181426805 hasAuthorship W3181426805A5061663931 @default.
• W3181426805 hasAuthorship W3181426805A5063480612 @default.
• W3181426805 hasAuthorship W3181426805A5068290703 @default.
• W3181426805 hasAuthorship W3181426805A5074659603 @default.
• W3181426805 hasAuthorship W3181426805A5084597097 @default.
• W3181426805 hasAuthorship W3181426805A5086084987 @default.
• W3181426805 hasAuthorship W3181426805A5090810460 @default.
• W3181426805 hasBestOaLocation W31814268051 @default.
• W3181426805 hasConcept C104317684 @default.
• W3181426805 hasConcept C126322002 @default.
• W3181426805 hasConcept C140704245 @default.
• W3181426805 hasConcept C142462285 @default.
• W3181426805 hasConcept C159047783 @default.
• W3181426805 hasConcept C159654299 @default.
• W3181426805 hasConcept C203014093 @default.
• W3181426805 hasConcept C22070199 @default.
• W3181426805 hasConcept C2522874641 @default.
• W3181426805 hasConcept C2779134260 @default.
• W3181426805 hasConcept C3007834351 @default.
• W3181426805 hasConcept C3008058167 @default.
• W3181426805 hasConcept C501734568 @default.
• W3181426805 hasConcept C524204448 @default.
• W3181426805 hasConcept C535046627 @default.
• W3181426805 hasConcept C542903549 @default.
• W3181426805 hasConcept C54355233 @default.
• W3181426805 hasConcept C71924100 @default.
• W3181426805 hasConcept C86803240 @default.
• W3181426805 hasConcept C8891405 @default.
• W3181426805 hasConceptScore W3181426805C104317684 @default.
• W3181426805 hasConceptScore W3181426805C126322002 @default.
• W3181426805 hasConceptScore W3181426805C140704245 @default.
• W3181426805 hasConceptScore W3181426805C142462285 @default.
• W3181426805 hasConceptScore W3181426805C159047783 @default.
• W3181426805 hasConceptScore W3181426805C159654299 @default.
• W3181426805 hasConceptScore W3181426805C203014093 @default.
• W3181426805 hasConceptScore W3181426805C22070199 @default.
• W3181426805 hasConceptScore W3181426805C2522874641 @default.
• W3181426805 hasConceptScore W3181426805C2779134260 @default.
• W3181426805 hasConceptScore W3181426805C3007834351 @default.

• next